To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene NDRG3TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
323 supporting clones for gene NDRG3 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
BP370056 testis .a 1 to 583 1 to 583   tiling clone,   583/583
(100 %)
2 diff
(99.7 %id)
DB458597 testis .a 19 to 492 1 to 474       474/474
(100 %)
1 diff
(99.8 %id)
BG723193 testis .a 39 to 696 1 to 656   tiling clone,   656/659
(99 %)
9 diff
(98.7 %id)
BP369302 testis .a 50 to 625 1 to 575       575/575
(100 %)
3 diff
(99.5 %id)
BP370737 testis .a 66 to 615 1 to 550       550/550
(100 %)
3 diff
(99.5 %id)
BP369119 testis .a 70 to 654 1 to 585   tiling clone,   585/585
(100 %)
1 diff
(99.9 %id)
BP370344 testis .a 72 to 630 1 to 558       558/558
(100 %)
12 diff
(97.9 %id)
BP371218 testis .a 72 to 638 1 to 567       567/567
(100 %)
1 diff
(99.9 %id)
DB089343 testis .a 73 to 621 2 to 551   capped   550/550
(100 %)
1 diff
(99.9 %id)
BP371097 testis .a 78 to 657 1 to 582       582/582
(100 %)
18 diff
(97.0 %id)
BP370211 testis .a 99 to 672 1 to 575       575/575
(100 %)
2 diff
(99.7 %id)
BP370960 testis .a 117 to 670 1 to 554       554/554
(100 %)
4 diff
(99.3 %id)
DA752788   .a 687 to 1265 2 to 580   tiling clone, capped   579/579
(100 %)
2 diff
(99.7 %id)
BP273413   .a 890 to 1467 1 to 579   tiling clone,   579/579
(100 %)
4 diff
(99.4 %id)
DA691400   .a 895 to 1463 2 to 570   tiling clone, capped   569/570
(99 %)
1 diff
(99.9 %id)
DA177415 amygdala .b 1 to 570 2 to 572   tiling clone, capped   571/571
(100 %)
2 diff
(99.7 %id)
AB044943   .b 3 to 2963 1 to 2963 exact tiling clone,   2963/2963
(100 %)
1 diff
(100.0 %id)
NM_032013.2   .b 3 to 2966 1 to 2964 exact RefSeq,   2964/2964
(100 %)
0 diff
(100 %id)
AU138025 placenta .b 4 to 724 2 to 722   capped   721/721
(100 %)
5 diff
(99.4 %id)
DN991337 brain, whole brain .b 6 to 572 8 to 574       567/574
(98 %)
0 diff
(100 %id)
DA389263 thalamus .b 7 to 577 2 to 572   capped   571/571
(100 %)
1 diff
(99.9 %id)
AF308609 Spleen .b 81 to 2959 1 to 2879 E32G     2879/2879
(100 %)
1 diff
(100.0 %id)
DA443187 tongue, tumor tissue .b 167 to 734 2 to 569   capped   568/568
(100 %)
0 diff
(100 %id)
AA113437   .b 216 to 595 1 to 390       390/394
(98 %)
13 diff
(96.8 %id)
BX479171   .b 229 to 716 1 to 488       488/488
(100 %)
1 diff
(99.8 %id)
BF573057 melanotic melanoma, high MDR, skin .b 253 to 844 1 to 600       600/604
(99 %)
20 diff
(96.7 %id)
BF573378 melanotic melanoma, high MDR, skin .b 253 to 844 1 to 596       594/871
(68 %)
11 diff
(98.8 %id)
DA394626 thalamus .b 261 to 842 2 to 583   capped   582/582
(100 %)
0 diff
(100 %id)
DA578490   .b 261 to 831 2 to 572   capped   571/571
(100 %)
0 diff
(100 %id)
DA144440 amygdala .b 262 to 838 2 to 578   capped   577/577
(100 %)
0 diff
(100 %id)
DA163074 amygdala .b 266 to 825 2 to 561   capped   560/560
(100 %)
0 diff
(100 %id)
DA395776 thalamus .b 267 to 865 2 to 600   capped   599/599
(100 %)
1 diff
(99.9 %id)
DA771621 brain .b 268 to 842 2 to 576   capped   575/575
(100 %)
0 diff
(100 %id)
AA325826 brain, cerebellum .b 284 to 730 1 to 449       449/449
(100 %)
2 diff
(99.6 %id)
AW964909   .b 285 to 844 1 to 551       551/565
(97 %)
23 diff
(96.0 %id)
DA075727 cerebellum .b 292 to 866 2 to 576   capped   575/575
(100 %)
0 diff
(100 %id)
DA504217 brain .b 293 to 850 2 to 560   capped   559/559
(100 %)
1 diff
(99.9 %id)
DA793972 brain .b 307 to 863 2 to 558   capped   557/557
(100 %)
0 diff
(100 %id)
DA514112 brain .b 314 to 854 2 to 542   capped   541/541
(100 %)
0 diff
(100 %id)
DB120132 thymus .b 352 to 911 2 to 561   capped   560/560
(100 %)
0 diff
(100 %id)
T85147 liver and spleen .b 358 to 673 9 to 326       318/350
(90 %)
11 diff
(96.9 %id)
DA165716 amygdala .b 377 to 949 2 to 574   capped   573/573
(100 %)
0 diff
(100 %id)
BF203986 muscle, rhabdomyosarcoma .b 433 to 1024 1 to 591       591/591
(100 %)
2 diff
(99.7 %id)
BM711792 eye, human retina .b 435 to 925 1 to 492   fully sequenced,   492/492
(100 %)
2 diff
(99.6 %id)
DA792329 brain .b 464 to 995 2 to 533   capped   532/532
(100 %)
0 diff
(100 %id)
DA295839 hippocampus .b 482 to 1048 2 to 569   capped   568/568
(100 %)
2 diff
(99.7 %id)
DA944032 Spleen .b 484 to 1055 2 to 573   capped   572/572
(100 %)
0 diff
(100 %id)
TI_2194644304   .b 540 to 1692 12 to 1160       1149/1265
(90 %)
15 diff
(98.9 %id)
BF807888 colon_ins .b 550 to 1069 30 to 548       519/548
(94 %)
10 diff
(98.2 %id)
TI_1971557253   .b 558 to 1647 1092 to 8       1085/1253
(86 %)
6 diff
(99.6 %id)
DA172466 amygdala .b 567 to 1134 2 to 569   capped   568/568
(100 %)
0 diff
(100 %id)
DA357792 subthalamic nucleus .b 572 to 1125 2 to 555   capped   554/554
(100 %)
0 diff
(100 %id)
DA866177 Prostate .b 572 to 1139 2 to 569   capped   568/568
(100 %)
0 diff
(100 %id)
DB180767 kidney, tumor tissue .b 572 to 1104 2 to 534   capped   533/533
(100 %)
0 diff
(100 %id)
AW003952 pooled germ cell tumors .b 574 to 1280 710 to 9       702/710
(98 %)
18 diff
(97.5 %id)
BM048594 carcinoma, cell line, Prostate .b 613 to 1414 1 to 800       800/800
(100 %)
10 diff
(98.8 %id)
AU132685   .b 642 to 1446 2 to 806   capped   805/805
(100 %)
2 diff
(99.8 %id)
DA059940 cerebellum .b 646 to 1224 2 to 580   capped   579/579
(100 %)
0 diff
(100 %id)
DA060016 cerebellum .b 651 to 1224 2 to 575   capped   574/574
(100 %)
0 diff
(100 %id)
DA057308 cerebellum .b 654 to 1224 2 to 573   capped   572/572
(100 %)
1 diff
(99.9 %id)
DA155525 amygdala .b 654 to 1213 2 to 561   capped   560/560
(100 %)
0 diff
(100 %id)
BM875677 insulinoma, Pancreas .b 690 to 1074 1 to 385   fully sequenced,   385/385
(100 %)
4 diff
(99.0 %id)
BQ020733 lung, Metastatic Chondrosarcoma .b 690 to 1333 662 to 19   AAA   644/644
(100 %)
0 diff
(100 %id)
DA867575 Prostate .b 718 to 1245 2 to 529   capped   528/528
(100 %)
1 diff
(99.9 %id)
DA179284 amygdala .b 720 to 1302 2 to 584   capped   583/583
(100 %)
1 diff
(99.9 %id)
DA504051 brain .b 720 to 1224 2 to 506   capped   505/505
(100 %)
0 diff
(100 %id)
DB119156 thymus .b 721 to 1290 2 to 571   capped   570/570
(100 %)
0 diff
(100 %id)
DA180835 amygdala .b 722 to 1282 2 to 562   capped   561/561
(100 %)
0 diff
(100 %id)
DA298451 hippocampus .b 722 to 1307 2 to 587   capped   586/586
(100 %)
0 diff
(100 %id)
DA056721 cerebellum .b 723 to 1282 2 to 561   capped   560/560
(100 %)
0 diff
(100 %id)
DA504143 brain .b 737 to 1294 2 to 559   capped   558/558
(100 %)
1 diff
(99.9 %id)
AW732397 Kidney, renal cell adenocarcinoma .b 766 to 1279 1 to 514     Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 514/514
(100 %)
6 diff
(98.9 %id)
BQ331773 lung_tumor .b 781 to 1329 26 to 576       551/578
(95 %)
19 diff
(96.8 %id)
BQ347201 nervous_tumor .b 781 to 997 4 to 221       218/227
(96 %)
14 diff
(93.9 %id)
DA394446 thalamus .b 788 to 1365 2 to 579   capped   578/578
(100 %)
2 diff
(99.7 %id)
AU129921   .b 794 to 1482 2 to 697   capped   696/697
(99 %)
12 diff
(98.3 %id)
BQ345914 nervous_tumor .b 795 to 1354 1 to 559       559/559
(100 %)
4 diff
(99.3 %id)
DA306701 hippocampus .b 819 to 1388 2 to 572   capped   571/571
(100 %)
2 diff
(99.7 %id)
DA302866 hippocampus .b 821 to 1393 2 to 574   capped   573/573
(100 %)
1 diff
(99.9 %id)
DB524099 testis .b 828 to 1286 1 to 459     Submitted on the opposite strand 459/460
(99 %)
1 diff
(99.8 %id)
DA181598 amygdala .b 835 to 1400 2 to 567   capped   566/566
(100 %)
0 diff
(100 %id)
AW594126 pooled germ cell tumors .b 841 to 1314 476 to 2       475/479
(99 %)
2 diff
(99.6 %id)
BQ346023 nervous_tumor .b 843 to 1261 29 to 447       419/447
(93 %)
2 diff
(99.6 %id)
T88705 liver and spleen .b 843 to 1280 446 to 1       446/469
(95 %)
10 diff
(97.9 %id)
AI004026 pooled .b 843 to 1333 494 to 5       490/502
(97 %)
1 diff
(99.9 %id)
DA064233 cerebellum .b 852 to 1419 2 to 569   capped   568/568
(100 %)
0 diff
(100 %id)
DB515010 testis .b 855 to 1289 1 to 435     Submitted on the opposite strand 435/436
(99 %)
5 diff
(98.9 %id)
DA160874 amygdala .b 857 to 1427 2 to 572   capped   571/571
(100 %)
2 diff
(99.7 %id)
BM665605 eye, human retina .b 864 to 1377 557 to 44   fully sequenced, AAA   514/539
(95 %)
0 diff
(100 %id)
AW590700 pooled germ cell tumors .b 886 to 1069 184 to 1       184/202
(91 %)
23 diff
(88.7 %id)
AA316771 lung .b 890 to 1216 1 to 330       330/330
(100 %)
4 diff
(98.8 %id)
BF436894 Prostate .b 892 to 1287 407 to 12   AAA   396/396
(100 %)
0 diff
(100 %id)
BM875426 insulinoma, Pancreas .b 912 to 1075 164 to 1   fully sequenced,   164/164
(100 %)
0 diff
(100 %id)
BQ308110 breast .b 944 to 1302 1 to 358       358/358
(100 %)
3 diff
(99.2 %id)
BQ306488 breast .b 945 to 1302 13 to 368       358/368
(97 %)
9 diff
(97.6 %id)
BQ306502 breast .b 945 to 1302 1 to 362       362/362
(100 %)
9 diff
(97.6 %id)
BQ306505 breast .b 947 to 1313 387 to 19       369/389
(94 %)
3 diff
(99.3 %id)
CN367765 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 975 to 1771 1 to 799       799/799
(100 %)
5 diff
(99.4 %id)
CV339283 breast .b 981 to 1157 1 to 176       176/176
(100 %)
18 diff
(89.8 %id)
AW384451 head_neck .b 1002 to 1438 441 to 4       438/441
(99 %)
0 diff
(100 %id)
DA061142 cerebellum .b 1010 to 1567 2 to 559   capped   558/558
(100 %)
1 diff
(99.9 %id)
BE504945 pooled germ cell tumors .b 1016 to 1287 271 to 1       271/291
(93 %)
12 diff
(95.9 %id)
DA598030   .b 1030 to 1577 2 to 549   capped   548/548
(100 %)
3 diff
(99.5 %id)
DA088942 cerebellum .b 1037 to 1600 2 to 565   capped   564/564
(100 %)
0 diff
(100 %id)
BG119245 adenocarcinoma, cell line, Liver .b 1043 to 1761 1 to 725       725/1109
(65 %)
32 diff
(97.2 %id)
BM791796 stomach .b 1045 to 1287 1 to 243       243/256
(94 %)
1 diff
(99.7 %id)
BM721040 eye, fetal eye .b 1066 to 1777 1 to 710     Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 710/710
(100 %)
2 diff
(99.8 %id)
AI743855 pooled .b 1067 to 1523 465 to 8       458/465
(98 %)
0 diff
(100 %id)
BQ640166 eye, retina .b 1076 to 1706 1 to 631       631/631
(100 %)
0 diff
(100 %id)
TI_1971556073   .b 1077 to 1249 173 to 3       171/173
(98 %)
0 diff
(100 %id)
AA609050   .b 1078 to 1314 239 to 3       237/239
(99 %)
0 diff
(100 %id)
AI598127 anaplastic oligodendroglioma, brain .b 1081 to 1522 444 to 3       442/444
(99 %)
0 diff
(100 %id)
BF082751 breast .b 1082 to 1554 473 to 1       473/473
(100 %)
2 diff
(99.6 %id)
DA251247 caudate nucleus .b 1083 to 1662 2 to 581   capped   580/580
(100 %)
1 diff
(99.9 %id)
BQ347182 nervous_tumor .b 1088 to 1439 359 to 2       358/374
(95 %)
0 diff
(100 %id)
AA349484 brain .b 1090 to 1396 1 to 307       307/307
(100 %)
1 diff
(99.7 %id)
AA113356   .b 1098 to 1522 427 to 1       427/428
(99 %)
2 diff
(99.6 %id)
AA136644   .b 1104 to 1572 1 to 477     Submitted on the opposite strand 477/477
(100 %)
9 diff
(98.2 %id)
BE907478 epithelioid carcinoma, Pancreas .b 1111 to 1819 1 to 701       701/845
(82 %)
18 diff
(97.9 %id)
AA578053 bone marrow, stem cells .b 1127 to 1400 274 to 1       274/281
(97 %)
4 diff
(98.6 %id)
DA068891 cerebellum .b 1134 to 1706 2 to 574   capped   573/573
(100 %)
0 diff
(100 %id)
CD692236 normal nasopharynx .b 1144 to 1717 34 to 606       573/606
(94 %)
6 diff
(99.1 %id)
BF034722 adenocarcinoma, ovary .b 1150 to 1638 37 to 527       491/527
(93 %)
6 diff
(98.9 %id)
AA204743   .b 1152 to 1528 1 to 378       378/378
(100 %)
1 diff
(99.8 %id)
TI_2194644308   .b 1168 to 2249 15 to 1098       1084/1290
(84 %)
28 diff
(97.9 %id)
TI_2194645875   .b 1168 to 2358 1252 to 69       1184/1293
(91 %)
0 diff
(100 %id)
BI254267 cervical carcinoma cell line, cervix .b 1180 to 1948 1 to 777       777/777
(100 %)
23 diff
(97.1 %id)
TI_2194642932   .b 1188 to 2358 1257 to 72       1186/1311
(90 %)
0 diff
(100 %id)
BF765338 colon_est .b 1195 to 1484 1 to 288       288/288
(100 %)
7 diff
(97.6 %id)
TI_2194644921   .b 1214 to 2358 1199 to 72       1128/1336
(84 %)
0 diff
(100 %id)
DA061919 cerebellum .b 1256 to 1824 2 to 571   capped   570/570
(100 %)
2 diff
(99.7 %id)
T26372   .b 1261 to 1569 1 to 309       309/309
(100 %)
6 diff
(98.1 %id)
T33663 brain .b 1261 to 1684 1 to 425       425/430
(98 %)
3 diff
(99.4 %id)
F12132 brain, total brain .b 1262 to 1599 1 to 338       338/338
(100 %)
0 diff
(100 %id)
FN052386 breast carcinoma .b 1270 to 1347 1 to 79       79/80
(98 %)
2 diff
(97.5 %id)
DA564623 heart .b 1274 to 1846 2 to 574   capped   573/573
(100 %)
0 diff
(100 %id)
DA089824 cerebellum .b 1277 to 1831 2 to 556   capped   555/555
(100 %)
0 diff
(100 %id)
AU157428 placenta .b 1281 to 1904 624 to 1       624/624
(100 %)
21 diff
(96.7 %id)
AA322907 brain, cerebellum .b 1286 to 1521 1 to 236       236/236
(100 %)
0 diff
(100 %id)
AA323106 brain, cerebellum .b 1286 to 1541 1 to 256       256/256
(100 %)
0 diff
(100 %id)
T66212 whole brain .b 1293 to 1726 13 to 459       447/459
(97 %)
6 diff
(98.7 %id)
BE086669 breast .b 1313 to 1529 1 to 217       217/217
(100 %)
6 diff
(97.3 %id)
BE086721 breast .b 1331 to 1588 1 to 254       254/268
(94 %)
8 diff
(97.1 %id)
BX951987   .b 1347 to 1931 1 to 585       585/585
(100 %)
0 diff
(100 %id)
BF927423 nervous_tumor .b 1360 to 1795 453 to 18     Submitted on the opposite strand 436/453
(96 %)
0 diff
(100 %id)
BM821220 stomach .b 1367 to 1862 1 to 496       496/496
(100 %)
0 diff
(100 %id)
BE086660 breast .b 1380 to 1755 1 to 376       376/376
(100 %)
0 diff
(100 %id)
BF843940 head_neck .b 1385 to 1891 522 to 17     Submitted on the opposite strand 506/522
(96 %)
0 diff
(100 %id)
AA421851 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .b 1390 to 1802 1 to 413       413/413
(100 %)
1 diff
(99.8 %id)
BG990683 head_neck .b 1392 to 1895 6 to 509       504/513
(98 %)
6 diff
(98.9 %id)
AW498963 brain .b 1427 to 1791 1 to 366       366/385
(95 %)
3 diff
(99.3 %id)
T09314   .b 1427 to 1828 1 to 403       403/403
(100 %)
2 diff
(99.6 %id)
T32914 adrenal gland .b 1432 to 1730 1 to 299       299/304
(98 %)
1 diff
(99.7 %id)
T33099 brain .b 1437 to 1892 1 to 459       459/459
(100 %)
3 diff
(99.4 %id)
AI372603   .b 1441 to 1923 15 to 502       488/502
(97 %)
4 diff
(99.3 %id)
CN367766 embryonic stem cells, cell lines H1, H7, andH9 .b 1467 to 2154 9 to 697       689/697
(98 %)
6 diff
(99.2 %id)
EH338330   .b 1471 to 1547 1 to 77       77/77
(100 %)
0 diff
(100 %id)
R56801 whole brain .b 1476 to 1848 1 to 379     Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 379/439
(86 %)
13 diff
(97.1 %id)
H23371 whole brain .b 1476 to 1848 1 to 379     Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 379/449
(84 %)
13 diff
(97.2 %id)
BU177085 melanotic melanoma, skin .b 1502 to 2215 1 to 714       714/890
(80 %)
9 diff
(99.0 %id)
AU124337   .b 1510 to 2339 2 to 825   capped   824/841
(97 %)
17 diff
(98.0 %id)
CB269432 adipose .b 1544 to 2116 1 to 573       573/573
(100 %)
1 diff
(99.9 %id)
BG744026 blood, natural killer cells, cell line .b 1558 to 2202 1 to 641   fully sequenced,   641/641
(100 %)
7 diff
(99.0 %id)
BE086673 breast .b 1581 to 1724 171 to 28     Submitted on the opposite strand 144/171
(84 %)
0 diff
(100 %id)
BE254381 eye, retinoblastoma .b 1581 to 2263 1 to 674       674/677
(99 %)
18 diff
(97.4 %id)
TI_149304065   .b 1592 to 2295 783 to 83   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 701/707
(99 %)
4 diff
(99.5 %id)
BM981949 lung, Primary Lung Cystic Fibrosis EpithelialCells .b 1607 to 2295 704 to 19   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 686/686
(100 %)
4 diff
(99.5 %id)
T31197 brain .b 1615 to 2016 1 to 403       403/403
(100 %)
1 diff
(99.8 %id)
BI871272 adenocarcinoma, cell line, Liver .b 1625 to 2194 1 to 574       574/799
(71 %)
6 diff
(99.3 %id)
TI_57230494   .b 1625 to 2194 105 to 678       574/799
(71 %)
6 diff
(99.3 %id)
CX759067 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .b 1629 to 2401 1 to 761     Submitted on the opposite strand 761/789
(96 %)
13 diff
(98.4 %id)
BE535539 cervix .b 1676 to 2313 1 to 663       663/672
(98 %)
41 diff
(93.9 %id)
CF146949 CNCAP(3)T-225 cell line, Prostate .b 1677 to 2320 8 to 651       644/655
(98 %)
5 diff
(99.3 %id)
TI_154179491   .b 1677 to 2506 74 to 897       824/827
(99 %)
18 diff
(97.9 %id)
BE872550 adenocarcinoma, colon .b 1714 to 2311 1 to 600       600/1098
(54 %)
6 diff
(99.5 %id)
BE086729 breast .b 1723 to 2016 305 to 8     Submitted on the opposite strand 298/305
(97 %)
0 diff
(100 %id)
BE086737 breast .b 1729 to 2089 414 to 54     Submitted on the opposite strand 361/414
(87 %)
0 diff
(100 %id)
CF141499 CNCAP(3)T-225 cell line, Prostate .b 1745 to 2196 1 to 452       452/452
(100 %)
4 diff
(99.2 %id)
TI_154172269   .b 1752 to 2204 80 to 532       453/459
(98 %)
1 diff
(99.8 %id)
T31149 brain .b 1753 to 2056 1 to 304       304/304
(100 %)
0 diff
(100 %id)
BG114934 duodenal adenocarcinoma, cell line, small intestine .b 1755 to 2475 1 to 713       713/956
(74 %)
21 diff
(97.9 %id)
EL952456 eyeball .b 1762 to 2201 1 to 439       439/439
(100 %)
4 diff
(99.1 %id)
AV722868 hypothalamus .b 1765 to 2462 1 to 688       688/706
(97 %)
24 diff
(96.7 %id)
TI_151726623   .b 1767 to 2140 425 to 52       374/978
(38 %)
0 diff
(100 %id)
BM727492 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .b 1768 to 2140 1 to 373       373/375
(99 %)
7 diff
(98.2 %id)
BE086691 breast .b 1786 to 2142 361 to 3     Submitted on the opposite strand 359/361
(99 %)
0 diff
(100 %id)
CD172027 White Matter .b 1799 to 2650 1 to 858       858/858
(100 %)
6 diff
(99.4 %id)
BF836399 head_neck .b 1811 to 2242 437 to 4     Submitted on the opposite strand 434/437
(99 %)
0 diff
(100 %id)
AI372605   .b 1839 to 2203 1 to 365       365/375
(97 %)
1 diff
(99.8 %id)
BE086687 breast .b 1843 to 2144 307 to 6     Submitted on the opposite strand 302/307
(98 %)
0 diff
(100 %id)
BQ268250 insulinoma, Pancreas .b 1847 to 2321 8 to 482     Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 475/486
(97 %)
1 diff
(99.8 %id)
T09034   .b 1854 to 2265 1 to 413       413/413
(100 %)
1 diff
(99.8 %id)
AA406202 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .b 2002 to 2298 333 to 37       297/333
(89 %)
0 diff
(100 %id)
BG744697 blood, natural killer cells, cell line .b 2187 to 2910 727 to 7   fully sequenced,   721/727
(99 %)
0 diff
(100 %id)
BM679477 eye, fetal eye .b 2227 to 2965 759 to 19   tiling clone, AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 741/741
(100 %)
1 diff
(99.9 %id)
BQ267985 insulinoma, Pancreas .b 2387 to 2960 590 to 17   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 574/574
(100 %)
1 diff
(99.9 %id)
DB369701   .b 2436 to 2959 524 to 1       524/527
(99 %)
8 diff
(98.5 %id)
DB367197   .b 2509 to 2960 451 to 1       451/460
(98 %)
2 diff
(99.6 %id)
R56802 whole brain .b 2522 to 2959 463 to 14   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 450/455
(98 %)
13 diff
(97.2 %id)
AA207127   .b 2559 to 2961 407 to 3       405/411
(98 %)
0 diff
(100 %id)
H23260 whole brain .b 2594 to 2959 393 to 14   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 380/380
(100 %)
18 diff
(95.3 %id)
AW733149 Kidney, renal cell adenocarcinoma .b 2648 to 2960 327 to 15   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 313/313
(100 %)
3 diff
(99.1 %id)
F09769 brain, total brain .b 2699 to 2960 262 to 1       262/262
(100 %)
0 diff
(100 %id)
DA788570 brain .c 1 to 592 2 to 588   tiling clone, capped   587/587
(100 %)
3 diff
(99.5 %id)
DA306440 hippocampus .c 58 to 611 2 to 555   tiling clone, capped   554/554
(100 %)
0 diff
(100 %id)
NM_022477.2   .c 60 to 2987 1 to 2928 exact RefSeq,   2928/2928
(100 %)
0 diff
(100 %id)
DA058734 cerebellum .c 61 to 573 2 to 514   capped   513/513
(100 %)
0 diff
(100 %id)
DA151141 amygdala .c 61 to 571 2 to 512   capped   511/514
(99 %)
1 diff
(99.9 %id)
DA307902 hippocampus .c 61 to 333 2 to 274   capped   273/273
(100 %)
0 diff
(100 %id)
AK027665   .c 71 to 2981 1 to 2911 F59S tiling clone, available from FLJ, AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 2911/2911
(100 %)
4 diff
(99.9 %id)
DA154773 amygdala .c 72 to 549 2 to 479   capped   478/487
(98 %)
0 diff
(100 %id)
DA736384   .c 72 to 797 2 to 727   capped   726/850
(85 %)
3 diff
(99.7 %id)
BC136489 Testicle, PCR rescued clones .c 83 to 2379 1 to 2296 exact tiling clone,   2296/2296
(100 %)
1 diff
(100.0 %id)
TI_1971557333   .c 84 to 1179 1108 to 19       1090/1271
(85 %)
11 diff
(99.2 %id)
DN997158 breast cancer, Mammary gland (cancer tissue) .c 101 to 748 8 to 655       648/655
(98 %)
6 diff
(99.1 %id)
DB368853   .c 2411 to 2981 566 to 1       566/566
(100 %)
14 diff
(97.6 %id)
DC424388   .d 1 to 795 1 to 792   tiling clone,   792/792
(100 %)
5 diff
(99.4 %id)
DC341836 thalamus .d 47 to 615 1 to 569   tiling clone,   569/569
(100 %)
0 diff
(100 %id)
AK295420 corpus callosum .d 50 to 1291 1 to 1242 S235L     1242/1242
(100 %)
1 diff
(100.0 %id)
DC329222 corpus callosum .d 50 to 611 1 to 562       562/562
(100 %)
0 diff
(100 %id)
TI_2194642928   .d 66 to 1228 44 to 1197 I51V L52F     1154/1277
(90 %)
30 diff
(97.7 %id)
TI_2194644912   .d 66 to 1202 43 to 1170 I51V L52F E280R V281C S282P ...     1128/1293
(87 %)
18 diff
(98.7 %id)
TI_2194645494   .d 66 to 1219 43 to 1183 I51V L52F     1141/1284
(88 %)
28 diff
(97.9 %id)
BC144169 Brain, cerebellum, PCR rescued clones .d 73 to 2177 1 to 2105 I51V L52F tiling clone,   2105/2105
(100 %)
2 diff
(100.0 %id)
CB217678 mandible, pooled .d 351 to 737 387 to 1     Submitted on the opposite strand 387/573
(67 %)
8 diff
(98.7 %id)
EC565035 Prostate .d 546 to 643 98 to 2       97/99
(97 %)
1 diff
(99.0 %id)
EC484429 Prostate .d 663 to 762 16 to 118       100/119
(84 %)
8 diff
(93.3 %id)
BU947451 insulinoma, Pancreas .d 1667 to 2141 8 to 486     Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 479/490
(97 %)
7 diff
(98.6 %id)
DA083239 cerebellum .d 1689 to 2165 2 to 478   capped   477/477
(100 %)
1 diff
(99.8 %id)
T30971 brain .d 1689 to 2033 1 to 347       347/347
(100 %)
3 diff
(99.2 %id)
CK003669 brain/CNS, Human Brain - Cerebellar Cortex .d 1704 to 2383 1 to 676       676/687
(98 %)
20 diff
(97.1 %id)
BQ130717 insulinoma, Pancreas .d 1707 to 2141 1 to 437     Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 437/438
(99 %)
8 diff
(98.2 %id)
BE315235 adenocarcinoma cell line, ovary .d 1713 to 2542 1 to 826       826/839
(98 %)
42 diff
(95.0 %id)
T33084 brain .d 1721 to 2007 1 to 287       287/287
(100 %)
0 diff
(100 %id)
BC001805.
matches multiple genes
Burkitt lymphoma, lymph, Lymph, Burkitt lymphoma .d 1731 to 2785 789 to 1844   available from MGC, AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base), also hits gene PIPOX 1056/1844
(57 %)
6 diff
(99.7 %id)
AV721866 hypothalamus .d 1793 to 2247 30 to 476       447/478
(93 %)
20 diff
(95.9 %id)
AW953143   .d 1813 to 2012 1 to 200       200/308
(64 %)
2 diff
(99.4 %id)
TI_154059022   .d 1937 to 2774 893 to 64   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 830/1009
(82 %)
50 diff
(95.1 %id)
BM686016 eye, Retina Foveal and Macular .d 1996 to 2361 1 to 367   fully sequenced,   367/367
(100 %)
8 diff
(97.9 %id)
BF757053 colon .d 2005 to 2192 11 to 196       186/197
(94 %)
15 diff
(92.4 %id)
BM685812 eye, Retina Foveal and Macular .d 2018 to 2363 1 to 339   fully sequenced, Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 339/339
(100 %)
4 diff
(98.9 %id)
EL945834 eyeball .d 2050 to 2543 36 to 530       495/530
(93 %)
6 diff
(98.9 %id)
BE897726 melanotic melanoma, skin .d 2053 to 2524 1 to 478       478/922
(51 %)
14 diff
(98.5 %id)
BU581135 Fetal Pancreas (4 Pooled Donors, 18 - 20weeks, Stratagene #738023) .d 2073 to 2579 1 to 507       507/507
(100 %)
1 diff
(99.9 %id)
CB135043 Liver .d 2075 to 2636 1 to 558       558/558
(100 %)
2 diff
(99.7 %id)
N40092 melanocyte .d 2087 to 2604 1 to 527       527/532
(99 %)
13 diff
(97.6 %id)
BQ009388 Chondrosarcoma, Left Pubic Bone .d 2119 to 2780 681 to 19   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 663/663
(100 %)
1 diff
(99.9 %id)
CB217677 mandible, pooled .d 2122 to 2611 13 to 503     Submitted on the opposite strand 491/603
(81 %)
5 diff
(99.2 %id)
CA437797 lung, Metastatic Chondrosarcoma .d 2137 to 2785 667 to 19   tiling clone, AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 649/649
(100 %)
0 diff
(100 %id)
BM988498 lung, Metastatic Chondrosarcoma .d 2139 to 2779 659 to 19   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 641/649
(98 %)
0 diff
(100 %id)
BU786240 insulinoma, Pancreas .d 2145 to 2780 652 to 17   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 636/636
(100 %)
1 diff
(99.9 %id)
AV722987 hypothalamus .d 2161 to 2759 597 to 1     Submitted on the opposite strand 597/613
(97 %)
20 diff
(96.8 %id)
BU580683 Fetal Pancreas (4 Pooled Donors, 18 - 20weeks, Stratagene #738023) .d 2232 to 2781 552 to 3       550/552
(99 %)
0 diff
(100 %id)
BI769254 pooled lung and spleen .d 2235 to 2780 1 to 546   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 546/546
(100 %)
0 diff
(100 %id)
TI_57179020   .d 2235 to 2780 32 to 577   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 546/577
(94 %)
6 diff
(99.0 %id)
DC427208   .d 2237 to 2780 544 to 1       544/547
(99 %)
8 diff
(98.6 %id)
DB305910.
matches multiple genes
brain .d 2244 to 2780 538 to 1     also hits gene yokeru 538/538
(100 %)
1 diff
(99.9 %id)
AA363003 ovary .d 2245 to 2478 9 to 244       236/244
(96 %)
6 diff
(97.6 %id)
BQ130462 insulinoma, Pancreas .d 2275 to 2780 522 to 17   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 506/513
(98 %)
1 diff
(99.9 %id)
AI819262 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) .d 2277 to 2781 506 to 2       505/506
(99 %)
0 diff
(100 %id)
EL946726 eyeball .d 2280 to 2718 1 to 438       438/438
(100 %)
5 diff
(98.9 %id)
T30418 colon, endothelial .d 2280 to 2610 1 to 330       330/330
(100 %)
2 diff
(99.4 %id)
EL953777 eyeball .d 2281 to 2600 1 to 320       320/320
(100 %)
9 diff
(97.2 %id)
BM999731 lung, Lung Focal Fibrosis .d 2290 to 2785 4 to 500   AAA Submitted on the opposite strand 497/500
(99 %)
7 diff
(98.6 %id)
AA322542 brain, cerebellum .d 2304 to 2492 1 to 189       189/189
(100 %)
0 diff
(100 %id)
AI289073 serous papillary carcinoma, high grade, 2pooled tumors, uterus .d 2307 to 2780 467 to 1       467/474
(98 %)
18 diff
(96.3 %id)
H49440 brain .d 2311 to 2761 1 to 457       457/458
(99 %)
7 diff
(98.5 %id)
TI_149271547   .d 2311 to 2785 558 to 84   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 475/921
(51 %)
0 diff
(100 %id)
BU674491 lung, Primary Lung Epithelial Cells .d 2311 to 2785 493 to 19   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 475/483
(98 %)
0 diff
(100 %id)
H51516 brain .d 2329 to 2760 447 to 1       447/449
(99 %)
18 diff
(96.0 %id)
BM663661 eye, Retina Foveal and Macular .d 2331 to 2786 466 to 11   fully sequenced,   456/466
(97 %)
5 diff
(99.0 %id)
BU726185 eye, Retina Foveal and Macular .d 2333 to 2780 465 to 18   fully sequenced, AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 448/448
(100 %)
0 diff
(100 %id)
BE798426 lung, small cell carcinoma .d 2339 to 2778 31 to 468       438/1054
(41 %)
6 diff
(99.5 %id)
AA969413 pooled .d 2340 to 2781 445 to 4       442/445
(99 %)
0 diff
(100 %id)
BE670187 carcinoid, lung .d 2345 to 2781 440 to 4       437/440
(99 %)
0 diff
(100 %id)
TI_154131153   .d 2352 to 2780 516 to 88   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 429/959
(44 %)
0 diff
(100 %id)
CA418050 Bone, Human Chondrosarcoma Cell Line .d 2354 to 2780 445 to 19   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 427/427
(100 %)
0 diff
(100 %id)
CA420077 Bone, Human Chondrosarcoma Cell Line .d 2354 to 2780 445 to 19   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 427/427
(100 %)
0 diff
(100 %id)
D20735   .d 2360 to 2679 1 to 323     Submitted on the opposite strand 323/460
(70 %)
4 diff
(99.2 %id)
BM693284 eye, Retina Foveal and Macular .d 2366 to 2785 1 to 420   fully sequenced, AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 420/420
(100 %)
0 diff
(100 %id)
BF800227 colon_ins .d 2371 to 2575 214 to 9     Submitted on the opposite strand 206/220
(93 %)
0 diff
(100 %id)
AW006205 anaplastic oligodendroglioma, brain .d 2371 to 2780 410 to 1       410/579
(70 %)
0 diff
(100 %id)
AA845639 parathyroid gland, parathyroid tumor .d 2374 to 2785 438 to 27   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 412/468
(88 %)
1 diff
(99.8 %id)
T33098 brain .d 2374 to 2780 407 to 1       407/407
(100 %)
0 diff
(100 %id)
BQ345505 nervous_tumor .d 2386 to 2561 190 to 18       173/190
(91 %)
0 diff
(100 %id)
BE328324 2 pooled Wilms' tumors, one primary and onemetastatic to brain, Kidney .d 2397 to 2780 384 to 1       384/384
(100 %)
0 diff
(100 %id)
AA633492 breast .d 2399 to 2779 391 to 11   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 381/395
(96 %)
0 diff
(100 %id)
AI083620 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .d 2399 to 2781 383 to 1       383/383
(100 %)
1 diff
(99.8 %id)
AI204945 schizophrenic brain S-11 frontal lobe .d 2399 to 2780 382 to 1       382/382
(100 %)
1 diff
(99.8 %id)
T03572   .d 2400 to 2785 391 to 1       391/437
(89 %)
7 diff
(98.4 %id)
AI026069 parathyroid gland, parathyroid tumor .d 2406 to 2785 389 to 11   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 379/388
(97 %)
1 diff
(99.8 %id)
AA903471 leiomyosarcoma, soft tissue .d 2417 to 2786 377 to 8   tiling clone,   370/377
(98 %)
0 diff
(100 %id)
EC515232 Prostate .d 2433 to 2549 1 to 116       116/116
(100 %)
9 diff
(92.3 %id)
BF000101 colon, colon tumor, RER+ .d 2436 to 2781 347 to 2       346/347
(99 %)
0 diff
(100 %id)
T32971 brain .d 2440 to 2780 341 to 1       341/341
(100 %)
0 diff
(100 %id)
AI372602   .d 2440 to 2780 344 to 1       344/360
(95 %)
3 diff
(99.2 %id)
AA311302   .d 2442 to 2780 1 to 339       339/339
(100 %)
0 diff
(100 %id)
AI686167 Prostate .d 2448 to 2780 345 to 13   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 333/333
(100 %)
0 diff
(100 %id)
AI659189 Prostate .d 2448 to 2780 343 to 11   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 333/333
(100 %)
0 diff
(100 %id)
BF436896 Prostate .d 2448 to 2780 345 to 13   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 333/333
(100 %)
0 diff
(100 %id)
AI435981 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .d 2457 to 2780 324 to 1       324/324
(100 %)
0 diff
(100 %id)
T03438   .d 2464 to 2785 322 to 1       322/322
(100 %)
1 diff
(99.7 %id)
AI049737   .d 2470 to 2781 339 to 28       312/349
(89 %)
0 diff
(100 %id)
AI049836   .d 2470 to 2780 339 to 29   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 311/321
(96 %)
0 diff
(100 %id)
BM702610 eye, human retina .d 2472 to 2780 1 to 310   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 310/310
(100 %)
1 diff
(99.7 %id)
BG819930 anaplastic oligodendroglioma with 1p/19qloss, brain .d 2474 to 2776 1 to 301   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 301/304
(99 %)
3 diff
(99.1 %id)
T33083 brain .d 2486 to 2785 300 to 1       300/300
(100 %)
0 diff
(100 %id)
AI972177 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .d 2492 to 2780 305 to 17   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 289/289
(100 %)
0 diff
(100 %id)
AA879206 metastatic prostate bone lesion .d 2507 to 2785 2 to 280   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 279/280
(99 %)
6 diff
(97.9 %id)
AI915975 colon, colon tumor, RER+ .d 2518 to 2781 267 to 3       265/269
(98 %)
0 diff
(100 %id)
AA613910   .d 2523 to 2781 8 to 266       259/276
(93 %)
1 diff
(99.7 %id)
AA853739 Bone, Hip .d 2526 to 2763 243 to 6       238/243
(97 %)
0 diff
(100 %id)
DR978094 brain .d 2528 to 2780 8 to 259   AAA Submitted on the opposite strand 252/259
(97 %)
6 diff
(97.7 %id)
AA136851   .d 2528 to 2770 245 to 1     Submitted on the opposite strand 245/245
(100 %)
2 diff
(99.2 %id)
AI971019.
matches multiple genes
cochlea, ear, Prostate .d 2536 to 2780 267 to 23   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base), also hits gene MAP9 245/245
(100 %)
4 diff
(98.4 %id)
AI027140 parathyroid gland, parathyroid tumor .d 2543 to 2780 255 to 18   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 238/238
(100 %)
0 diff
(100 %id)
AI620528 Prostate .d 2548 to 2781 236 to 3       234/236
(99 %)
0 diff
(100 %id)
AI637519 pooled germ cell tumors .d 2556 to 2780 235 to 11   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 225/225
(100 %)
0 diff
(100 %id)
AW497594   .d 2563 to 2763 203 to 1       203/207
(98 %)
2 diff
(99.1 %id)
AI972307 Prostate .d 2596 to 2780 209 to 25   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 185/185
(100 %)
0 diff
(100 %id)
BF054861 brain, oligodendroglioma .d 2662 to 2781 1 to 120       120/125
(96 %)
6 diff
(95.2 %id)
AA928615 pooled germ cell tumors .d 2665 to 2781 121 to 4       118/121
(97 %)
0 diff
(100 %id)
BM664128 eye, Retina Foveal and Macular .d 2710 to 2791 94 to 13   fully sequenced, Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 82/94
(87 %)
5 diff
(94.7 %id)
AK295466 hippocampus .e 1 to 1328 5 to 1332 exact tiling clone,   1332/1332
(100 %)
1 diff
(100.0 %id)
DC330073 hippocampus .e 1 to 545 5 to 549       549/549
(100 %)
1 diff
(99.9 %id)
DB449739 testis .f 1 to 430 1 to 431   tiling clone,   431/431
(100 %)
2 diff
(99.6 %id)
CX763064 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .f 375 to 1094 37 to 755   tiling clone, Submitted on the opposite strand 728/760
(95 %)
13 diff
(98.3 %id)
DA469227   .g 1 to 566 2 to 568 L9P T10H E11R I12D K13Q ... tiling clone, capped   567/567
(100 %)
3 diff
(99.5 %id)
DA190514 amygdala .h-u 1 to 585 2 to 586   tiling clone, capped   585/585
(100 %)
0 diff
(100 %id)
DB239178 trachea .h-u 225 to 811 2 to 588 exact capped   587/587
(100 %)
0 diff
(100 %id)
AK128068 testis .h-u 386 to 4385 1 to 4000 exact tiling clone, available from FLJ,   4000/4000
(100 %)
0 diff
(100 %id)
DB064391 testis .h-u 387 to 959 2 to 574 exact capped   573/573
(100 %)
0 diff
(100 %id)
BP432399   .h-u 595 to 969 1 to 375       375/375
(100 %)
0 diff
(100 %id)
BP432428   .h-u 597 to 1013 1 to 420       420/420
(100 %)
3 diff
(99.3 %id)
DA099574 cerebellum .h-u 755 to 1320 2 to 567   capped   566/566
(100 %)
0 diff
(100 %id)
DA227817 brain .h-u 806 to 1355 2 to 551   capped   550/550
(100 %)
0 diff
(100 %id)
DA118963 cerebellum .h-u 1148 to 1709 2 to 563   capped   562/562
(100 %)
0 diff
(100 %id)
DA401507 thalamus .h-u 1223 to 1691 2 to 470   capped   469/469
(100 %)
0 diff
(100 %id)
DB131802 thymus .h-u 1392 to 1929 2 to 539   capped   538/538
(100 %)
0 diff
(100 %id)
DA769069 brain .h-u 1490 to 1985 2 to 497   capped   496/496
(100 %)
0 diff
(100 %id)
BF953020 nervous_normal .h-u 2025 to 2532 1 to 507       507/507
(100 %)
9 diff
(98.3 %id)
DB325628 brain .h-u 3844 to 4385 543 to 1       543/543
(100 %)
1 diff
(99.9 %id)
DB339558 testis .h-u 3849 to 4385 537 to 1       537/537
(100 %)
0 diff
(100 %id)
DB039929 testis .i 1 to 583 2 to 584   tiling clone, capped   583/583
(100 %)
0 diff
(100 %id)
AF251054   Gene NDRG3, variant not shown         This clone was ignored    
AK023618 placenta Gene NDRG3, variant not shown       available from FLJ, Suspected internal deletion, this clone was ignored    
BG699299 brain, hippocampus Gene NDRG3, variant not shown         This clone was ignored    
BQ185201 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid Gene NDRG3, variant not shown         This clone was ignored    
BQ188014 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid Gene NDRG3, variant not shown         This clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h-u, .i Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes C